Published in J Clin Microbiol on September 23, 2009
The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One (2011) 1.96
Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol (2014) 1.76
Human enterovirus 71 epidemics: what's next? Emerg Health Threats J (2013) 1.54
Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J Gen Virol (2010) 1.48
Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One (2011) 1.45
The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol (2013) 1.32
Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis (2012) 1.31
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Quantifying antigenic relationships among the lyssaviruses. J Virol (2010) 1.27
Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008. Virol J (2010) 1.26
Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol (2010) 1.25
Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One (2012) 1.24
Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLoS Negl Trop Dis (2013) 1.18
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One (2012) 1.12
Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci (2014) 1.12
Antigenic and receptor binding properties of enterovirus 68. J Virol (2013) 1.11
Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One (2013) 1.09
Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. PLoS Med (2015) 1.09
Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09. PLoS Negl Trop Dis (2012) 1.06
Production of EV71 vaccine candidates. Hum Vaccin Immunother (2012) 1.05
The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog (2015) 1.03
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One (2013) 1.01
Genetic relationship between cocirculating Human enteroviruses species C. PLoS One (2011) 1.00
Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One (2014) 1.00
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One (2013) 1.00
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. PLoS Med (2016) 0.99
Enterovirus 71 infection of monocytes with antibody-dependent enhancement. Clin Vaccine Immunol (2010) 0.98
Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J (2011) 0.92
A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein. PLoS Negl Trop Dis (2014) 0.91
Immunological evaluation and comparison of different EV71 vaccine candidates. Clin Dev Immunol (2012) 0.91
Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines. Viruses (2015) 0.91
Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol (2011) 0.91
Molecular evolution of enterovirus 68 detected in the Philippines. PLoS One (2013) 0.91
Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. PLoS One (2013) 0.90
Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan. PLoS One (2013) 0.89
Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet Nam. J Virol (2015) 0.89
Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam, 2011. PLoS One (2013) 0.88
Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012. PLoS One (2015) 0.87
Immunological and biochemical characterization of coxsackie virus A16 viral particles. PLoS One (2012) 0.86
Relapse of hand foot and mouth disease: are we at more risk? Indian J Dermatol (2013) 0.86
Development and evaluation of reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71. BMC Infect Dis (2011) 0.85
Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development. PLoS Negl Trop Dis (2014) 0.84
Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS One (2013) 0.83
Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease. Eur J Clin Microbiol Infect Dis (2012) 0.83
Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution. J Virol (2015) 0.82
Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses (2012) 0.82
Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci (2014) 0.82
Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis. Virol J (2015) 0.82
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71. J Virol Methods (2015) 0.82
(PS)2: protein structure prediction server version 3.0. Nucleic Acids Res (2015) 0.81
Reemergence of enterovirus 71 epidemic in northern Taiwan, 2012. PLoS One (2015) 0.81
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations. BMC Med (2015) 0.80
Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS One (2015) 0.80
Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71. J Biomed Sci (2014) 0.80
Complete genome sequence of a human enterovirus 71 strain isolated in brunei in 2006. Genome Announc (2013) 0.79
The Fecal Virome of Children with Hand, Foot, and Mouth Disease that Tested PCR Negative for Pathogenic Enteroviruses. PLoS One (2015) 0.78
Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate. PLoS One (2014) 0.77
Antigenic Relationships among Human Pathogenic Orientia tsutsugamushi Isolates from Thailand. PLoS Negl Trop Dis (2016) 0.77
Cyclical Patterns of Hand, Foot and Mouth Disease Caused by Enterovirus A71 in Malaysia. PLoS Negl Trop Dis (2016) 0.76
Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques. PLoS One (2014) 0.76
An atypical winter outbreak of hand, foot, and mouth disease associated with human enterovirus 71, 2010. BMC Infect Dis (2014) 0.75
Epidemiologic Features of Enterovirus 71-Associated Hand-Foot-and-Mouth Disease from 2009 to 2013 in Zhejiang, China. Int J Environ Res Public Health (2016) 0.75
Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia. Emerg Microbes Infect (2016) 0.75
Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res (2017) 0.75
EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. BMC Res Notes (2016) 0.75
Characterization of VP1 sequence of Coxsackievirus A16 isolates by Bayesian evolutionary method. Virol J (2016) 0.75
Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands. Emerg Infect Dis (2016) 0.75
Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clin Exp Vaccine Res (2015) 0.75
Phylogeography of coxsackievirus A16 reveals global transmission pathways and recent emergence and spread of a recombinant genogroup. J Virol (2017) 0.75
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun (2017) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med (1999) 11.06
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics (2005) 8.62
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis (1974) 6.22
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
Inferring evolutionary trees with PAUP*. Curr Protoc Bioinformatics (2003) 4.19
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol (2005) 3.82
Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol (2001) 3.80
Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis (2007) 3.79
Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int (2004) 3.06
Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis (2003) 2.98
Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol (2002) 2.64
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis (1999) 2.52
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res (1999) 2.40
Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol (2006) 2.33
Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol (2005) 2.26
Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol (2008) 2.24
An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis (2006) 2.17
New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses. Emerg Infect Dis (2009) 2.16
Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis (2007) 2.13
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Using MODELTEST and PAUP* to select a model of nucleotide substitution. Curr Protoc Bioinformatics (2003) 1.82
Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000. Arch Virol (2003) 1.75
A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005. J Infect Dis (2008) 1.75
Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J (2006) 1.65
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol (2003) 1.64
Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis (2003) 1.63
(PS)2: protein structure prediction server. Nucleic Acids Res (2006) 1.59
Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol (2006) 1.58
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol (2007) 1.50
The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res (2008) 1.45
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect (2007) 1.36
Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis (2008) 1.36
An outbreak of enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. J Clin Virol (2000) 1.27
Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera stored frozen for two decades. Bull World Health Organ (1985) 1.27
Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog (2009) 1.24
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Virus Res (2007) 1.23
Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg Infect Dis (2004) 1.21
Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res (2007) 1.18
Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol (2005) 1.14
Molecular mechanisms of poliovirus variation and evolution. Curr Top Microbiol Immunol (2006) 1.11
Detecting signatures of selection from DNA sequences using Datamonkey. Methods Mol Biol (2009) 1.01
Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection. Virol J (2005) 0.92
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology (2010) 4.44
Gain-of-function experiments on H7N9. Science (2013) 3.67
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (2013) 3.38
Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. Crit Care Med (2013) 2.88
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74
Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 2.69
Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol (2009) 2.64
Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol (2002) 2.64
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology (2008) 2.55
Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis (2003) 2.36
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Autophagic machinery activated by dengue virus enhances virus replication. Virology (2008) 2.23
Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis (2005) 2.18
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature (2013) 2.17
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology (2003) 2.15
A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol (2004) 2.10
A new urinary antigen test score correlates with severity of pneumococcal pneumonia in children. J Formos Med Assoc (2011) 2.05
Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan. J Formos Med Assoc (2013) 2.02
Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol (2006) 2.02
SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis (2004) 1.95
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol (2004) 1.87
Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem (2004) 1.86
RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology (2005) 1.85
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
An interferon-gamma-related cytokine storm in SARS patients. J Med Virol (2005) 1.83
Establishing a nationwide emergency department-based syndromic surveillance system for better public health responses in Taiwan. BMC Public Health (2008) 1.81
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother (2006) 1.76
Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J Med Virol (2007) 1.69
Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin Infect Dis (2003) 1.68
Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis (2004) 1.67
Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A (2004) 1.66
Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci (2006) 1.64
Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci (2009) 1.61
Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol (2007) 1.61
Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis (2008) 1.59
Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology (2012) 1.59
Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol (2006) 1.58
Type I interferons protect mice against enterovirus 71 infection. J Gen Virol (2005) 1.57
Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol (2011) 1.55
Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc (2011) 1.53
Quantifying the impact of immune escape on transmission dynamics of influenza. Science (2009) 1.50
A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol (2004) 1.49
Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J Gen Virol (2010) 1.48
High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology (2009) 1.46
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43
Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol (2003) 1.39
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst (2005) 1.35
Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology (2005) 1.35
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology (2013) 1.35
Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology (2009) 1.33
Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis (2012) 1.31
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae. Antimicrob Agents Chemother (2007) 1.28
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis (2008) 1.28
Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol (2005) 1.26
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.23
Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol (2005) 1.21
Septic arthritis in children: relationship of causative pathogens, complications, and outcome. J Microbiol Immunol Infect (2003) 1.20
Association of NRAMP 1 gene polymorphism with susceptibility to tuberculosis in Taiwanese aboriginals. J Formos Med Assoc (2006) 1.20
Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer (2004) 1.19
Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001--2002. J Trop Pediatr (2004) 1.19
Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res (2007) 1.18
Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J Clin Microbiol (2005) 1.18
Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology (2009) 1.16
Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol (2007) 1.16
Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr Infect Dis J (2009) 1.16
Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol (2006) 1.15
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res (2007) 1.14
Genetic diversity of the Mycobacterium tuberculosis Beijing family based on SNP and VNTR typing profiles in Asian countries. PLoS One (2012) 1.13
Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011. J Virol (2013) 1.13
Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol (2005) 1.13
Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma. Mod Pathol (2010) 1.12
Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci (2014) 1.12
Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology (2013) 1.12